-
1
-
-
84872243414
-
-
Mifepristone (Mifeprex) product information, (accessed 2011 Sept 28)
-
Mifepristone (Mifeprex) product information. www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm111323.htm (accessed 2011 Sept 28).
-
-
-
-
2
-
-
84872252934
-
-
Guttmacher Institute. Fact sheet August 2011, (accessed 2011 Sept 28)
-
Guttmacher Institute. Fact sheet August 2011. http://www.guttmacher. org/pubs/fb_induced_abortion.html (accessed 2011 Sept 28).
-
-
-
-
4
-
-
0024745094
-
Termination of pregnancy in the privacy of one's home
-
Potts M Termination of pregnancy in the privacy of one's home. N C Med J 1989;50:531-6.
-
(1989)
N C Med J
, vol.50
, pp. 531-536
-
-
Potts, M.1
-
5
-
-
77649188555
-
A novel mifepristone-loaded implant for long-term treatment of endometriosis: In vitro and in vivo studies
-
Mei L, Bao J, Tang L, et al. A novel mifepristone-loaded implant for long-term treatment of endometriosis: in vitro and in vivo studies. Eur J Pharm Sci 2010;39:421-7.
-
(2010)
Eur J Pharm Sci
, vol.39
, pp. 421-427
-
-
Mei, L.1
Bao, J.2
Tang, L.3
-
6
-
-
0142210295
-
Progesterone antagonist and progesterone receptor modulators
-
Spitz IM. Progesterone antagonist and progesterone receptor modulators. Expert Opin Investig Drugs 2003;12:1693-707.
-
(2003)
Expert Opin Investig Drugs
, vol.12
, pp. 1693-1707
-
-
Spitz, I.M.1
-
7
-
-
36549032804
-
Mifepristone (RU-486) in Cushing's syndrome
-
Johansen S, Allolio B. Mifepristone (RU-486) in Cushing's syndrome. Eur J Endocrinol 2007;157:561-9.
-
(2007)
Eur J Endocrinol
, vol.157
, pp. 561-569
-
-
Johansen, S.1
Allolio, B.2
-
8
-
-
0037051129
-
Mifepristone: Bioavailability, pharmacokinetics and use-effectiveness
-
Sarkar NN. Mifepristone: bioavailability, pharmacokinetics and use-effectiveness. Eur J Obstet Gynaecol Reprod Biol 2002;101:113-20.
-
(2002)
Eur J Obstet Gynaecol Reprod Biol
, vol.101
, pp. 113-120
-
-
Sarkar, N.N.1
-
9
-
-
1642579548
-
The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestins action
-
Heikinheimo O, Kekkonen R, Lahteenmaki P. The pharmacokinetics of mifepristone in humans reveal insights into differential mechanisms of antiprogestins action. Contraception 2003;68:421-6.
-
(2003)
Contraception
, vol.68
, pp. 421-426
-
-
Heikinheimo, O.1
Kekkonen, R.2
Lahteenmaki, P.3
-
10
-
-
84872255257
-
-
Drug Bank. Progesterone, (accessed 2011 Oct 8)
-
Drug Bank. Progesterone. http://www.drugbank.ca/drugs/DB00396 (accessed 2011 Oct 8).
-
-
-
-
11
-
-
84872230753
-
-
United States Department of Labor Occupational Safety & Health Administration, (accessed 2011 Nov 2)
-
United States Department of Labor Occupational Safety & Health Administration. http://www.osha.gov/dts/sltc/methods/partial/pv2001/2001. html (accessed 2011 Nov 2).
-
-
-
-
12
-
-
84872244318
-
-
United States Department of Labor Occupational Safety & Health Administration, (accessed 2011 Nov 2)
-
United States Department of Labor Occupational Safety & Health Administration. http://www.osha.gov/dts/sltc/methods/partial/pv2001/2001. html (accessed 2011 Nov 2).
-
-
-
-
13
-
-
0032580484
-
Early pregnancy termination with mifepristone and misoprostol
-
Spitz IM, Bardin W, Benton L, Robbins A, et al. Early pregnancy termination with mifepristone and misoprostol. N Engl J Med 1998;338:1241-7.
-
(1998)
N Engl J Med
, vol.338
, pp. 1241-1247
-
-
Spitz, I.M.1
Bardin, W.2
Benton, L.3
Robbins, A.4
-
14
-
-
0030897554
-
Vaginal misoprostol administered at home after mifepristone for medical abortion
-
Schaff EA, Stadalius LS, Eisinger, SH, Franks P. Vaginal misoprostol administered at home after mifepristone for medical abortion. J Fam Pract 1997;44:353-60.
-
(1997)
J Fam Pract
, vol.44
, pp. 353-360
-
-
Schaff, E.A.1
Stadalius, L.S.2
Eisinger, S.H.3
Franks, P.4
-
16
-
-
0034107964
-
Low dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days
-
Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000;61:41-6.
-
(2000)
Contraception
, vol.61
, pp. 41-46
-
-
Schaff, E.A.1
Fielding, S.L.2
Eisinger, S.H.3
Stadalius, L.S.4
Fuller, L.5
-
17
-
-
0033660891
-
A comparison of ARM and Population Council trials
-
Schaff EA, Fielding SL. A comparison of ARM and Population Council trials. J Am Med Womens Assoc 2000;55(3 suppl):137-40.
-
(2000)
J Am Med Womens Assoc
, vol.55
, Issue.3 SUPPL.
, pp. 137-140
-
-
Schaff, E.A.1
Fielding, S.L.2
-
18
-
-
84872229819
-
High failure rates of medical termination of pregnancy after introduction to a large teaching hospital
-
(accessed 2012 July 5)
-
Swica Y, Winikoff B. High failure rates of medical termination of pregnancy after introduction to a large teaching hospital. Fertil Steril 2008. https://fertstert.wordpress.com/2008/10/30/high-failure-rates-of-medical termination-of-pregnancy-after-introduction-to-a-large-teaching-hospital/ (accessed 2012 July 5).
-
(2008)
Fertil Steril
-
-
Swica, Y.1
Winikoff, B.2
-
20
-
-
84872260100
-
-
NaProTECHNOLOGY. Unleashing the power in a woman's cycle: progesterone support in pregnancy, (accessed 2012 Jul 5)
-
NaProTECHNOLOGY. Unleashing the power in a woman's cycle: progesterone support in pregnancy. http://www.naprotechnology.com/ progesterone. htm (accessed 2012 Jul 5).
-
-
-
|